Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35809374

Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2022 Sep
First author
Hingorani P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hingorani P
      type
      Author
    2. name
      Krailo M
      type
      Author
    3. name
      Buxton A
      type
      Author
    4. name
      Hutson P
      type
      Author
    5. name
      Sondel PM
      type
      Author
    6. name
      Diccianni M
      type
      Author
    7. name
      Yu A
      type
      Author
    8. name
      Morris CD
      type
      Author
    9. name
      Womer RB
      type
      Author
    10. name
      Crompton B
      type
      Author
    11. name
      Randall RL
      type
      Author
    12. name
      Teot LA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hingorani P
      type
      Author
    2. name
      Krailo M
      type
      Author
    3. name
      Buxton A
      type
      Author
    4. name
      Hutson P
      type
      Author
    5. name
      Sondel PM
      type
      Author
    6. name
      Diccianni M
      type
      Author
    7. name
      Yu A
      type
      Author
    8. name
      Morris CD
      type
      Author
    9. name
      Womer RB
      type
      Author
    10. name
      Crompton B
      type
      Author
    11. name
      Randall RL
      type
      Author
    12. name
      Teot LA
      type
      Author
    bibliography ids
    1. nci-bib-f643b5335c8204de7fce71d8
    book metadata
    content sha256
    4284516f2af85cd223e9c291e02465cc399df9bcd3721c6b3234d3535ed2efef
    document type
    citation
    dois
    1. 10.1016/j.ejca.2022.05.035
    electronic publication date
    display
    2022 Jul 6
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35809374
    immutable id
    pubmed:35809374@4284516f2af85cd223e9c291e02465cc399df9bcd3721c6b3234d3535ed2efef
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    1879-0852
    issn print
    0959-8049
    issue
    Source null
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    264-275
    volume
    172
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35809374
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      2ebe2cf00d80d73071d69419c72133594f11667e6c76d626e4a868e6b8cd6a5f
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2022 Sep
      precision
      month
      year
      2022
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35809374/
      title
      Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice